engleski

R&D Efficiency for Pharmaceutical Companies in the EU

This study constructs research and development (R&D) as a factor of productivity of European pharmaceutical industry. We introduce an empirical model derived from the Data Envelopment Analysis model to calculate R&D and efficiencies for selected European pharmaceutical companies. This research brings a mathematical view with Data Envelopment Analysis which is a mathematical modeling method of calculating relative efficiencies of Decision Making Units (DMUs), based on predetermined inputs and outputs. Performance evaluation of R&D activity is important for continuous improvement of performance of pharmaceutical companies. The model was used to obtain the overall level of exports with input factors of R&D activity. The subject of analysis are efficiency values and rank. After identifying relative efficiencies of the observed countries, the results are discussed.

DEA efficiency ; R&D performance ; EU pharmaceutical companies

nije evidentirano